These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 21864078)

  • 1. Cell replacement therapy for Parkinson's disease: how close are we to the clinic?
    Ganz J; Lev N; Melamed E; Offen D
    Expert Rev Neurother; 2011 Sep; 11(9):1325-39. PubMed ID: 21864078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells.
    Taylor H; Minger SL
    Curr Opin Biotechnol; 2005 Oct; 16(5):487-92. PubMed ID: 16143504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering a dopaminergic phenotype in stem/precursor cells: role of Nurr1, glia-derived signals, and Wnts.
    Arenas E
    Ann N Y Acad Sci; 2005 May; 1049():51-66. PubMed ID: 15965107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease.
    Lindvall O; Kokaia Z
    Trends Pharmacol Sci; 2009 May; 30(5):260-7. PubMed ID: 19362379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell therapy for Parkinson's disease: problems and prospects.
    Björklund A
    Novartis Found Symp; 2005; 265():174-86; discussion 187, 204-211. PubMed ID: 16050257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell-based therapy for Parkinson's disease.
    Correia AS; Anisimov SV; Li JY; Brundin P
    Ann Med; 2005; 37(7):487-98. PubMed ID: 16278162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cells may reshape the prospect of Parkinson's disease therapy.
    Sonntag KC; Simantov R; Isacson O
    Brain Res Mol Brain Res; 2005 Mar; 134(1):34-51. PubMed ID: 15790528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The search for a curative cell therapy in Parkinson's disease.
    Laguna Goya R; Tyers P; Barker RA
    J Neurol Sci; 2008 Feb; 265(1-2):32-42. PubMed ID: 17936303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem-cell-based strategies for the treatment of Parkinson's disease.
    Parish CL; Arenas E
    Neurodegener Dis; 2007; 4(4):339-47. PubMed ID: 17627139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell transplantation in the damaged adult brain.
    Jaber M; Benoit-Marand M; Prestoz L; Gaillard A
    Rev Neurol (Paris); 2013 Nov; 169(11):838-43. PubMed ID: 24112517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural grafting in Parkinson's disease Problems and possibilities.
    Brundin P; Barker RA; Parmar M
    Prog Brain Res; 2010; 184():265-94. PubMed ID: 20887880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
    Chen W; Huang Q; Ma S; Li M
    ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease.
    Levy YS; Bahat-Stroomza M; Barzilay R; Burshtein A; Bulvik S; Barhum Y; Panet H; Melamed E; Offen D
    Cytotherapy; 2008; 10(4):340-52. PubMed ID: 18574767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell therapy for Parkinson's disease: Functional role of the host immune response on survival and differentiation of dopaminergic neuroblasts.
    Wenker SD; Leal MC; Farías MI; Zeng X; Pitossi FJ
    Brain Res; 2016 May; 1638(Pt A):15-29. PubMed ID: 26239914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell transplantation and gene therapy in Parkinson's disease.
    Wakeman DR; Dodiya HB; Kordower JH
    Mt Sinai J Med; 2011; 78(1):126-58. PubMed ID: 21259269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal cell replacement in Parkinson's disease.
    Hedlund E; Perlmann T
    J Intern Med; 2009 Oct; 266(4):358-71. PubMed ID: 19765180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental perspectives on human midbrain-derived neural stem cells.
    Schwarz J
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S466-8. PubMed ID: 18267285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restorative approaches in Parkinson's Disease: which cell type wins the race?
    Meyer AK; Maisel M; Hermann A; Stirl K; Storch A
    J Neurol Sci; 2010 Feb; 289(1-2):93-103. PubMed ID: 19733367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells.
    Isacson O; Bjorklund LM; Schumacher JM
    Ann Neurol; 2003; 53 Suppl 3():S135-46; discussion S146-8. PubMed ID: 12666105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.